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Abstract Children represent about 1% of all patients with
urolithiasis, but 100% of these children are considered high
risk for recurrent stone formation, and it is crucial for them
to receive a therapy that will render them stone free. In
addition, a metabolic workup is necessary to ensure a
tailored metaphylaxis to prevent or delay recurrence. The
appropriate therapy depends on localization, size, and
composition of the calculus, as well as on the anatomy of
the urinary tract. In specialized centers, the whole range of
extracorporeal shock-wave lithotripsy (ESWL), ureterore-
noscopy (URS), and percutaneous nephrolithotomy
(PCNL) are available for children, with the same efficiency
and safety as in adults.
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Introduction
Children presenting with urolithiasis pose a challenge to the
treating doctor, as they are part of the high-risk group for
stone recurrence [1]. Although a rare disease in children
living in developed countries, with a prevalence of between
1:1,000 and 1:7,600 in different parts of the USA, the
number of pediatric patients per capita is increasing [2, 3].
For the pediatric patient, especially being a high-risk
patient, it is of utmost importance that no stone material is
left behind, no matter what therapy is employed, as
recurrence rates are higher than in adults. Thirty-three
percent of patients with small remaining stone fragments
after extracorporeal shock-wave lithotripsy (ESWL)
(<3 mm), which were formerly called clinically insignificant
residual fragments (CIRFs) in the early era of ESWL, had an
increasing stone mass on median follow-up of 24 months [4].
In a study conducted by Afshar et al., 69% of patients with
residual fragments ≤5 mm on mean follow-up of 48 months
after ESWL had symptomatic episodes or an increase in
stone size [5]. Compared with stone-free individuals, patients
with residual fragments had an increased risk for adverse
clinical outcome, with an odds ratio (OR) of 3.9. If an
underlying metabolic disorder was existent, the OR for
growth of residual fragments was 11.4 [5]. This begs the
question: Is ESWL still the best treatment for urolithiasis, or
could other—i.e. endourological therapy—be better suited?
The standard procedures to treat pediatric urolithiasis do
not differ from those used for adults: ESWL, ureteroreno-
scopy (URS), percutaneous nephrolithotomy (PCNL), and—
in selected cases—laparoscopic surgery. Open surgery is
reserved for selected cases, especially those with the need for
anatomicalcorrectionofthe urinary tract.Before choosingthe
appropriate treatment, it is indispensable to know the number,
size,location,andcompositionofa stone,andinaddition,any
informationabouttheurinarytractbelowthestone.Therefore,
in our opinion, adequate imaging is obligatory.
Extracorporeal shock-wave lithotripsy
ESWL was first reported by Chaussy et al. in 1980 and has
since changed the management of stone disease in adults
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introduced into the pediatric setting after Newman et al.
reported its safety and effectiveness in 1986. At the time,
ten of the 15 children were stone free, and three had small
residual fragments [7]. The underlying function of all types
of ESWL machines is to generate and focus shock-wave
energy at a focal point that is clustered at the calculus.
Ideally, the impact of the shock wave disintegrates the stone
so the fragments can pass the ureter. It is known that ESWL
is safe in adults, but there has been concern in the past that
the high-energy impact may negatively affect kidney
development [8]. Brinkmann et al. found no effect of
ESWL on renal function or blood pressure, and there was
no sign of renal scarring in children [9]. In addition,
hematuria and proteinuria resolved after patients were stone
free [9]. Lottmann and colleagues analyzed the treatment of
15 children aged 9 months to 15 years. They found no
changes in blood pressure or signs of acquired parenchymal
scarring 6 months after ESWL using 99 m-Tc dimercapto-
succinate (DMSA) renal scans for evaluation [10]. Vlajkovic
et al. evaluated glomerular filtration rate (GFR) using
99 m-Tc diethylenetriamine pentaacetic acid (DTPA) before,
directly after, and 3 months after ESWL. The first
measurement after ESWL showed a significant decrease in
GFR, from 118 ± 7 ml/min pretreatment to 107 ± 6 ml/min
posttreatment. On further follow-up, GFR normalized or
even improved to 121 ± 6 ml/min 3 months after ESWL.
GFR was 131 ± 10 ml/min at the end of the observation
period (average of 3 years). The authors concluded that
ESWL is a safe treatment in children [11].
Studies conducted to investigate short- or long-term
effects demonstrate that there are short-term effects such as
perirenal hematomas, hematuria, and reduced GFR directly
after ESWL therapy. However, there has been no evidence
for long-term damage in children [12–15]. One long-term
study reported in adults by Krambeck et al. needs to be
mentioned. Krambeck and colleagues conducted an epide-
miologic study based on questionnaires 19 years after
ESWL, the longest available follow-up after ESWL to date.
According to the results, patients treated with ESWL were
more prone to develop hypertension (OR 1.47), especially
after bilateral treatment (p=0.033), than controls with
nephrolithiasis not treated surgically. There was also an
increased risk of developing diabetes mellitus compared
with controls (OR 3.23). The risk of diabetes mellitus was
directly related to treatment intensity and the amount of
shock waves delivered (p=0.007; p=0.005, respectively)
[16]. Results of Krambeck et al.’s retrospective study are
questionable, as the control group had less severe urolithiasis
and no individuals in the control arm with bilateral ESWL
treatment [17]. Also, the authors grouped patients who had
ESWL for kidney stones with patients who received ESWL
for proximal ureter stones, which could make a significant
difference considering the different focus of the shock waves.
Knoll and colleagues prospectively examined 12 patients to
determine whether they developed acute endocrine pancreatic
injury after ESWL for renal stones and could not detect any
effect on endocrine or exocrine pancreatic function. They
therefore concluded it is unlikely that ESWL and diabetes
mellitus are related [18].
ESWL is the preferred treatment in pediatric urolithiasis
patients with calculi <20 mm. Stone-free rates after ESWL
in children range between 57% and 92% [19–21]. In
suspected cystine stones, the maximum diameter should
not exceed 15 mm because of the hardness of the stone
[18]. With growing endourologic options and the known
hardness of cystine stones, a ureteroscopic or minipercuta-
neous nephrolithotomy (mini-PCNL, or mini-Perc) approach
is coequal, if not the new first-line therapy. Thus, large and
hard stones such as cystine and whewellite decrease ESWL
success rates [22].
Another important aspect in treatment planning is urinary
tract anatomy and stone location. ESWL treatment of stones
in lower calices has a lower success rate due to the special
anatomy and gravity situation, as noted by Sampaio and
Aragao in 1992, anatomists, who suggested including the
knowledge of the specific anatomy of a patient into
treatment planning [23]. Tan and colleagues examined the
radiological anatomy of their pediatric patients. They
demonstrated that there is a significant difference between
mean lower pole infundibular length (p=0.0032) and lower
infundibulopelvic angle between stone-free cases and
others. Interestingly, stone burden or infundibular width
did not play a role in stone-free rates. A cutoff angle of 40°
for the infundibulopelvic−ureteropelvic angle was an excel-
lent method to predict the clearance of lower pole fragments
after ESWL. The stone-free rate in this series of 34 patients
was 55.9% (the average stone-free rate for lower caliceal
stones being 50−62% in other representative series) [24–27].
Spontaneous stone passage is easier in children compared
with adults, and ureter stenting is not needed as often (only 5–
37%) as it is in adults [28–30]. Nevertheless, these patients
should receive pharmacological support to pass their stone
fragments. For pain control, acetaminophen and ibuprofen
are the medication of choice, as passing fragments can cause
colic. Alfa 1a adrenergic receptor antagonist, such as
tamsulosin, can be used (off label) to facilitate the passage
of fragments through the intramural part of the ureter [31,
32]. Even though ESWL can cause minor complications,
including hematuria, bruising, renal colic, and perirenal
hematoma, it is important to be aware that in children (up
to the age of 14), all therapeutic approaches require
anesthesia. Therefore, if a therapy is likely to be unsuccessful
the first time, it may be better to use another technique
that assures that the patient is stone free after one procedure
[33–35].
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According to the guidelines of the European Association of
Urology, ESWL should be the first choice for most renal
pediatric stones, but a percutaneous approach could be used
for bigger and more complex calculi [20]. To gain access to
the renal pelvis or renal calices for a percutaneous
nephrolithotomy, it is necessary to puncture a renal calyx
under ultrasound guidance. Fluoroscopy is generally
employed as soon as the puncture is successful. The
puncture channel is dilated and the instrument inserted to
start fragmentation and elimination of the stone under
permanent videoscopy. For stone fragmentation, pneumatic
lithoclast probes, ultrasound probes, or holmium:yttrium
aluminum garnet (Ho:YAG) laser probes can be used. Stone
fragments can then be captured with special wire baskets or
graspers, which can be inserted through the working
channel of the instrument.
Being a safe procedure in adults, PCNL is a safe
procedure in adults and was first described in children by
Woodside et al. in 1985, having been performed in seven
children, with 100% stone removal in one session, using
standard adult instruments (24–34 F) [36]. PCNL in
children has since become easier, after Jackman et al.
introduced the mini-perc technique using an instrument
with only 11 F compared with the 24- to 34-F sized
instruments [37]. In that series, the stone-free rate was 85%,
whereas the numbers in the current literature range between
86.9% and 98.5% [38–40]. With this new technique, it is
even possible to render 89% of patients with staghorn
calculi stone free in one session [41].
Although there are no international guidelines as to
when PCNL should be the primary treatment in children,
there are relative indications, such as large stones
(>1.5 cm) or >1 cm for lower-pole concrements.
Especially if there are anatomical abnormalities that
prevent good fragment clearance (i.e. ureteropelvic
junction obstruction, calyceal diverticulum, ureter stricture),
and depending on stone composition, PCNL can be the
treatment of choice [22, 42].
As was the case with ESWL, there was concern about
renal scarring and loss of renal function (or other long-term
effects) due to PCNL. Dawaba et al. used DMSA renal
scans to search for renal scarring after PCNL but found
none, whereas others found minimal scarring [40, 43].
Dawaba et al. also used DTPA renal scans to follow-up
renal function after PCNL and noted that except for one
patient (out of 65), renal function improved or stabilized
after percutaneous procedure [40]. Reported complications
of PCNL include postoperative fever (30%) and bleeding,
the latter being the most reported complication associated
with PCNL and consecutive transfusion rates ranging from
0%to23.9% [37, 38, 44–48]. The risk for blood transfusions
is generally very low, with the report of one transfusion in
287 procedures in four pediatric studies [38, 44, 45, 47]. The
highest reported number of transfusions needed (23.9%, or
16 out of 67) was by Zeren et al., which occurred mainly
during their early PCNL procedures. The authors compared
the 16 patients who received blood transfusions to the those
who did not and found a significant difference between stone
burden, sheath size, and operative time [46]. Although
PCNL is an invasive treatment, it achieves excellent stone-
free rates and comes with a relatively low risk in experienced
hands, especially if performed as mini-perc. It is always
necessary to keep in mind that the child should be stone free
after one treatment; therefore, a good preselection to every
treatment is the key to success.
Ureterorenoscopy
URS for concrements in the distal ureter in children was
first reported by Ritchey et al. in 1988, with stone-free rates
in the early series of 86–100% [48–54]. URS has become
available in children due to the invention of smaller
diameter ureteroscopic instruments. Today, pediatric rigid
endoscopes of 4.5 F and good applicable tools are routinely
available. Rigid and flexible endoscopes are on the market,
with rigid endoscopes providing a bigger working channel,
whereas flexible endoscopes can bend up to 270° and are
especially useful for removing stones in the lower calices.
URS is ideally suited for calculi in the mid and distal ureter.
De Dominicis et al. compared URS and ESWL in 31
children in a randomized fashion. After one treatment, 94%
(16 of 17) of patients were stone free in the URS-treated
group compared with 43% (6 of 14) in the ESWL group
(64% after two sessions) [51]. There was a concern that due
to the instrumentation—dilation of the ureteral orifice—
vesicoureteral reflux and strictures might follow stone
removal via URS. However, Schuster et al. found in a
literature review of 221 URSs in children that only two
patients had ureteral strictures and eight had low-grade
vesicoureteral reflux [50].
As complications do not seem to differ compared with
URS in adults, this procedure (including in the proximal
and intrarenal calculi) has become a first-line treatment for
stone disease in pediatric patients in many clinics [50, 52,
53, 55–57]. All those series reported excellent stone-free
rates. Unfortunately, it was not possible to examine the
stone-free rate for proximal or intrarenal calculi separately,
as the number of reported cases is limited. Cannon et al.
treated 21 patients with a mean age of 15 years. The
success rate of lower-pole calculi removal was 76% [57].
Tanaka et al. evaluated 52 URS procedures for intrarenal
calculi [58] and found that retrograde endoscopy for
intrarenal calculi was safe, and there was a primary stone-
free rate of 50% after one procedure. With a mean follow-
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Predictors for further treatment were younger age and
preoperative stone size >6 mm. Re-treatment was not
necessary if the stone size ≤6 mm. That study clearly
demonstrates that treatment of lower-pole stones often
requires additional treatment, no matter what kind of
therapy is first used. Pearle et al. reported a prospective
randomized trial comparing ESWL and URS for lower-pole
c a l c u l iu pt o1c m[ 59]. On radiographic follow-up
3 months after the procedures, 35% of patients with
ESWL were rendered stone free, whereas this was true
for 50% of patients in the URS group. This difference
did not achieve statistical significance, but there were
more complications in the URS group (1 vs. 7). Thus,
ureteroscopy has become a first-line treatment for ureteral
stonesandcanevenbeconsidereda goodtreatment optionfor
renal calculi.
Laparoscopic surgery/open surgery
In developed countries, open surgery remains the treatment
of choice for 0.3–5.4% of children. In general patients
with anatomical abnormalities—i.e. ureteropelvic junction
obstruction, obstructive megaureter, urolithiasis—will receive
open surgery if stone removal and anatomical correction can
be combined in one operation [60]. In developing countries,
open surgery is used in 14% of cases, which is likely due to
the fact that open surgery is more cost effective in those
countries [61]. Zargooshi et al. reported a 95.4% stone-free
rate in the treated children and even 100% for single stones.
Casale et al. successfully used a transperitoneal laparoscopic
pyelolithotomy in eight children, with a mean stone burden
of 2.9 cm after percutaneous access had failed [62]. One
hundred percent of their patients were stone free afterward,
although one patient had a recurrence at 12 month follow-up.
Between 2002 and 2005, five adolescents (mean age
16.6 years) underwent robot-assisted laparoscopic pyeloli-
thotomy. One patient had to be converted to an open
procedure due to inability to remove the staghorn stone.
Three of the four other patients were stone free after surgery,
and one had a remaining lower-pole calculus of 6 mm. The
authors stated that the procedure is safe and efficacious but
that its role in stone management needs to be determined
[63].
Conclusion
Due to the miniaturization of instruments and better optic
and ancillary instruments, the use of ESWL is decreasing.
With the primary goal of complete stone removal in one
session to prevent recurrence from residual fragments,
endoscopic treatment is on the rise.
Questions
(Answers follow the reference list)
1. The incidence of stone disease in children is increasing.
How many of them are considered high risk for
recurrence?
a. 25%
b. 50%
c. 75%
d. 95%
e. 100%
2. What is not a typical side effect of ESWL?
a. Hematuria
b. Proteinuria
c. Increased GFR
d. Renal colic
e. Perirenal hematoma
3. For a 2-year-old child who presents with a 1-cm stone
in the left renal pelvis and no known anatomical
problems, the treatment of choice is:
a. PCNL
b. ESWL
c. URS
d. Mini-Perc
e. Laparoscopic surgery
4. For the treatment of an intrarenal stone, the following
variables need to be considered. Which one is NOT one
of them?
a. Gender
b. Stone size
c. Patient age
d. Urinary tract anatomy
e. Stone location
5. Anesthesia in children is not required for:
a. ESWL
b. URS
c. PCNL
d. Mini-Perc
e. Metabolic intervention
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